0000950170-23-033420.txt : 20230718 0000950170-23-033420.hdr.sgml : 20230718 20230718180456 ACCESSION NUMBER: 0000950170-23-033420 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230717 FILED AS OF DATE: 20230718 DATE AS OF CHANGE: 20230718 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LAPORTE KATHLEEN CENTRAL INDEX KEY: 0001196201 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39122 FILM NUMBER: 231095208 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 89bio, Inc. CENTRAL INDEX KEY: 0001785173 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831114349 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 142 SANSOME STREET STREET 2: SECOND FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: (415) 432-9270 MAIL ADDRESS: STREET 1: 142 SANSOME STREET STREET 2: SECOND FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94104 4 1 ownership.xml 4 X0508 4 2023-07-17 0001785173 89bio, Inc. ETNB 0001196201 LAPORTE KATHLEEN C/O 89BIO, INC. 142 SANSOME STREET, 2ND FLOOR SAN FRANCISCO CA 94104 true false false false false Common Stock 2023-07-17 4 M false 12500 2.64 A 12500 D Common Stock 2023-07-17 4 S false 12500 18.80 D 0 D Stock Option (Right to Buy) 2.64 2023-07-17 4 M false 12500 0 D 2032-05-16 Common Stock 12500 12500 D This transaction was executed in multiple trades at prices ranging from $18.77 to $18.90. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. This option is vested in full. /s/ Ryan A. Murr, as attorney-in-fact for Kathleen LaPorte 2023-07-18